Skip to main content
NIH funding notice RFA-HG-20-014

Novel Synthetic Nucleic Acid Technology Development (R01 Clinical Trial not allowed)

Closed on February 4, 2022.

Posted
March 19, 2020
Close date
February 4, 2022
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

4 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $3,612,967 in first-year total cost, median $901,685.

Most frequent study sections

  1. Special Emphasis Panel[ZHG1 HGR-M (J1)]2
  2. Special Emphasis Panel[ZHG1 HGR-M (O1)]1
  3. Special Emphasis Panel[ZHG1 HGR-M (O2)]1

Most frequent institutions

  1. DNA SCRIPT1
  2. FOUNDATION FOR APPLIED MOLECULAR EVOLUTN1
  3. NEW YORK UNIVERSITY SCHOOL OF MEDICINE1
  4. STANFORD UNIVERSITY1
Competing awards under RFA-HG-20-014 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2023The Assemblatron1R01HG012743-01BOEKE, JEF DNEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY$1,029,181ZHG1
2022Multiplexed In Vivo DNA Assembly1R01HG011676-01A1LEVY, SASHA FSHERLOCK, GAVIN JSTANFORD UNIVERSITY, CA$1,075,060ZHG1
2021Enzymatic Synthesis of RNA1R01HG011669-01BENNER, STEVEN APOMERANTZ, RICHARD TFOUNDATION FOR APPLIED MOLECULAR EVOLUTN, FL$774,189ZHG1
2021A low-cost benchtop oligonucleotide synthesizer using inkjet enzymatic DNA synthesis1R01HG011736-01HORGAN, ADRIANDNA SCRIPT$734,537ZHG1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

RFA-HG-20-014: Novel Synthetic Nucleic Acid Technology Development (R01 Clinical Trial not allowed) | ScienceDex | ConductScience